Kefir Usual Consumers and New Kefir Consumers
Conditions
Keywords
Digestive wellbeing, Quality of life, Gut Microbiome
Brief summary
The study aims at generating first real-world insights into how consumers perceive the benefits of consuming Activia Kefir on their digestive wellbeing, overall wellbeing, and to explore its potential effects on the gut microbiome.
Interventions
OTHERCommercialized dairy product consumption and stool samples collection
Consumption of 280 mL (1 bottle) Activia Kefir drinkable per day during the two-weeks study period and collection of 2 stools samples using a collection kit at participant's home (before and after product consumption)
Sponsors
Danone Global Research & Innovation Center
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
1. Males and females aged 18 years and older at the time of screening; 2. Willingness to consume Activia Kefir and complete the requested questionnaires; 3. Living in the designated locations in Spain, able to read and write in Spanish; 4. Have a personal electronic device compatible and connectable to internet (i.e., computer, laptop, smartphone) to fill the questionnaires; 5. Signed informed consent.
Exclusion criteria
1. People that currently participate in another study with (dairy) investigational or marketed products; 2. Severely immunocompromised individuals (e.g., post-transplant, advanced HIV/AIDS, undergoing chemotherapy); 3. Individuals with known allergies or intolerances to product ingredients. For lactose maldigestion, kefir may improve tolerance, so individuals who are aware of their condition and still wish to participate can be included.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Stool frequency (number of stools/week, single-item) | After 2 weeks of study product consumption | Difference between after consumption and baseline |
| Digestive symptoms frequency questionnaire (DSFQ, frequency of 4 symptoms: abdominal pain/discomfort, bloating, flatulence, borborygmi) | After 2 weeks of study product consumption | Difference between after consumption and baseline |
| Gastrointestinal (GI)-wellbeing (single-item question) | After 2 weeks of study product consumption | Difference between after consumption and baseline |
| Stool consistency (Bristol stool scale, single-item) | After 2 weeks of study product consumption | Difference between after consumption and baseline |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PROMIS global health questionnaire (10-item, includes questions about emotional state fatigue, pain, general health, quality of life, physical health, mental health, satisfaction social activities, usual activities, and everyday physical activities) | After 2 weeks of study product consumption | Difference between after consumption and baseline |
| WHO wellbeing questionnaire (5-items, includes questions about cheerful/good spirits, calm/relaxed, active/vigorous, feeling fresh/rested, daily life with things that interest me) | After 2 weeks of study product consumption | Difference between after consumption and baseline |
| Perceived resilience (using the 2-item Connor-Davidson Resilience Scale (CD-RISC)-2) | After 2 weeks of study product consumption | Difference between after consumption and baseline |
Countries
Spain
Contacts
CONTACTDanone Global Research & Innovation Center
Outcome results
None listed